To determine whether hepatitis C virus (HCV) replicates in bone marrow, we investigated positive-and negative-strand HCV RNA in bone marrow cells and fluids, and sera from patients with HCV infection. The study population consisted of 15 patients positive for antibodies to HCV (anti-HCV). Positive-and negative-strands HCV RNA were detected using highly strandspecific rTth reverse transcription-polymerase chain reaction (rTth RT-PCR) followed by Southern blotting analysis. Positive-strand HCV RNA was detected in 12 (80%) serum samples, in 13 (86.7%) bone marrow fluid specimens, and in 6 (40.0%) bone marrow cell samples. Negativestrand HCV RNA was detected in 9 (60.0%) serum samples, 11 (91.7%) fluid specimens, while it was not detected in bone marrow cells. The absence of negative-strand HCV RNA in bone marrow cells suggested that HCV does not replicate in these cells. Negative-strand HCV RNA detected in serum and bone marrow fluid samples may have been due to contamination with circulating HCV RNA from hepatocytes.
INTRODUCTION
Hepatitis C virus (HCV) is the major etiological agent responsible for parenterally transmitted non-A, non-B hepatitis [1, 2] . HCV is a small enveloped, positive-strand RNA virus, which appears to have a similar genetic organization to the pesti-or flaviviruses [3] . The viral genome is comprised of a single-strand positive-sense RNA that is translated into a large polyprotein, which is post-translationally processed to yield the structural and nonstructural viral proteins [4, 5] . As HCV appears to replicate via a negative-strand RNA intermediate, active replication in infected cells is demonstrated by the detection of negative-strand complementary to the genomic RNA [4] . Thus, detection of negative-strand HCV RNA in infected cells is considered a marker of active viral replication. The presence of HCV negative-strand RNA has not only been reported in liver but also in serum [6, 7] , peripheral blood mononuclear cells (PBMC) [8] [9] [10] , and bone marrow cells [1 1] . On the other hand, different studies have recently indicated that the previous strand-specific methods to detect negative-strand HCV RNA lack strand specificity [12] [13] [14] [15] . In this study, to investigate whether HCV can replicate in bone marrow cells in patients with hepatitis C, both positive-and negativestrands of RNA in bone marrow cells, fluids, and serum from anti-HCV positive patients were investigated, using highly specific rTth RT PCR [14, 15] .
MATERIALS AND METHODS

Patients
Subjects were 15 patients positive for anti-HCV admitted to our institute between April, 1993, and August, 1994. Table 1 shows the clinical background of the subjects including diagnosis, platelets, white . However, other researchers suggested that negative-strand HCV RNA detected in exrrahepatic sites may be due to contamination with plasma and/or adherence of circulating virus because methods for detecting negative-strand HCV RNA lack sufficient strand specificity [12-15] . Therefore, we examined both strands of HCV RNA using highly strand-specific rTth RT PCR [14, 15] . Negativestrand HCV RNA was detected in serum and bone marrow fluids samples, while it was not found in any bone marrow cell samples. Both positive-and negattve-strand HCV RNA detected in serum and bone marrow fluids samples might have been due to contamination and/or adherence of circulating HCV RNA. To detect HCV RNA more precisely, another important point is sensitivity. In this study, we used single-step PCR with a 32P-labeled probes. It was reported that the sensitivity of this method was equivalent to that of nested PCR, which is considered the reference assay [16] . Thus, the sensitivity of our RT-PCR assay may also have been equal to that of nested PCR. From these observations, we conclude that HCV infection in bone marrow cells may be transient rather than replicative.
In this study, we semi-quantitatively examined both positive-and negative-strand HCV RNAs in serum and bone marrow (fluids and cells). Titers of both HCV RNAs in serum were almost equivalent to those of in bone marrow fluid, but were significantly greater than those in bone marrow cells. Although the number of subjects examined was limited and it is questionable whether we can correctly compare HCV RNA levels in different tissues (serum and bone marrow fluids or serum and bone marrow cells), these findings also suggest that both positiveand negative-strand HCV RNA detected in bone marrow fluid and positive-strand HCV RNA detected in bone marrow cell samples might have been due to contamination and/or adherence of circulating HCV RNA.
In chronic hepatitis C patients, pretreatment serum hepatitis C virus RNA levels are one of the main prognostic factors of sustained response to IFN therapy [18, 19] 
